MX2, a morpholino anthracycline, as a new antitumor agent against drug-sensitive and multidrug-resistant human and murine tumor cells.

Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil.

1981 • 1,463 citations

Intensely potent morpholinyl anthracyclines

1984 • 136 citations

Comparative cytotoxicities of various morpholinyl anthracyclines

1985 • 39 citations

Evaluation of response rates to various antitumor agents of human gastric tumors implanted in nude mouse.

1986 • 31 citations

New morpholino anthracyclines, MX, MX2, and MY5.

1987 • 24 citations

Antitumor activity of new morpholino anthracyclines.

1988 • 21 citations

Cellular pharmacology of 3'-(4-morpholinyl) and 3'-(4-methoxy-1-piperidinyl) derivatives of 3'-deaminodaunorubicin in human colon carcinoma cells in vitro.

1983 • 20 citations

Cellular pharmacology of 3'-(3-cyano-4-morpholinyl)-3'-deaminoadriamycin and structural analogues in human colon carcinoma HT-29 cells in vitro.

1987 • 6 citations